Dr. Caywood is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1600 Rockland Road
Wilmington, DE 19803Phone+1 302-651-4200Fax+1 302-651-5510
Summary
- Dr. Emi Caywood is a pediatric hematologist/oncologist in Wilmington, DE and is affiliated with multiple hospitals in the area, including Thomas Jefferson University Hospitals, Alfred I. duPont Hospital for Children, and Nemours Children's Hospital. She received her medical degree from Rutgers Robert Wood Johnson Medical School and has been in practice 15 years. She is experienced in myeloid leukemia and pediatric bone marrow transplantation.
Education & Training
- Johns Hopkins UniversityFellowship, Pediatric Hematology/Oncology, 2005 - 2008
- MedStar Health/Georgetown University HospitalResidency, Pediatrics, 2002 - 2005
- Rutgers Robert Wood Johnson Medical SchoolClass of 2002
Certifications & Licensure
- DE State Medical License Active through 2025
- PA State Medical License Active through 2024
- MD State Medical License 2005 - 2010
- DC State Medical License 2004 - 2005
- VA State Medical License 2002 - 2005
- American Board of Pediatrics Pediatric Hematology-Oncology
- American Board of PediatricsHematology/Oncology
Clinical Trials
- Metformin in Children With Relapsed or Refractory Solid Tumors Start of enrollment: 2012 Sep 24
- Sorafenib and Topotecan in Refractory/Recurrent Pediatric Malignancies Start of enrollment: 2013 Jan 01
- Bosutinib in Pediatric Patients With Newly Diagnosed Chronic Phase or Resistant/Intolerant Ph + Chronic Myeloid Leukemia Start of enrollment: 2020 Apr 06
Roles: Contact, Principal Investigator
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsSymptom Screening Linked to Care Pathways for Pediatric Patients With Cancer: A Randomized Clinical Trial.L Lee Dupuis, Emily Vettese, Allison C Grimes, Melissa P Beauchemin, Lisa M Klesges
JAMA. 2024-12-17 - Phase II Trial of Gemcitabine and Nab-Paclitaxel for Recurrent Osteosarcoma with Serial Monitoring Using Liquid Biopsy: A Report from the National Pediatric Cancer Fou...Aditi Dhir, Masanori Hayashi, Avery Bodlak, Javier Oesterheld, David M Loeb
Clinical Cancer Research. 2024-12-02 - Relevance of lymphocyte proliferation to PHA in severe combined immunodeficiency (SCID) and T cell lymphopenia.Roshini S Abraham, Amrita Basu, Jennifer R Heimall, Elizabeth Dunn, Alison Yip
Clinical Immunology. 2024-04-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: